Amicus Therapeutics vs Orchard Therapeutics
Amicus Therapeutics vs Orchard Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Amicus Therapeutics is on 57/100 and Orchard Therapeutics on 51/100.
Where each one leads
Amicus Therapeutics
- our overall score: 57/100 against 51/100
- headcount: 625 against 248
- funding raised: $200M against $125M
Orchard Therapeutics
- agent readiness: 39/100 against 21/100
At a glance
| Measure | Amicus Therapeutics | Orchard Therapeutics |
|---|---|---|
| What it is | Biotechnology company focused on developing treatments for rare metabolic diseases. | Gene therapy company developing treatments for rare inherited diseases. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotech | Services |
| Founded | 2002 | 2015 |
| Headquarters | Philadelphia, United States | Boston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Amicus Therapeutics | Orchard Therapeutics |
|---|---|---|
| Employees | 625 | 248 |
| Total funding | $200M | $125M |
| Latest round | Series D | IPO |
| LinkedIn followers | 57,431 | 54,964 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Amicus Therapeutics | Orchard Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 57/100 | 51/100 |
| Traction | 60/100 | 60/100 |
| Team | 30/100 | 30/100 |
| Search visibility | 34/100 | 25/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 66/100 | 60/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Amicus Therapeutics | Orchard Therapeutics |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Tag Manager |
Amicus Therapeutics vs Orchard Therapeutics: common questions
Which is better, Amicus Therapeutics or Orchard Therapeutics?
On our 0-100 score Amicus Therapeutics rates higher (57/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Amicus Therapeutics and Orchard Therapeutics compare on the numbers?
Amicus Therapeutics leads on our overall score (57/100 against 51/100), headcount (625 against 248), funding raised ($200M against $125M). Orchard Therapeutics leads on agent readiness (39/100 against 21/100).
Read the full Amicus Therapeutics review and pricing or the Orchard Therapeutics review and pricing. You can also browse other Amicus Therapeutics alternatives we track.